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Elias Johansson1* and Per Wester2Abstract
Background: Recurrent TIAs are thought to signal a high stroke risk. The aim of this study is to examine if repeated
ischemic events increase the risk of recurrent ipsilateral stroke among patients with symptomatic 50-99% carotid
stenosis.
Methods: This is a secondary analysis of the ANSYSCAP study, where we analyzed recurrent ipsilateral ischemic
stroke before carotid endarterectomy in 230 consecutive patients with symptomatic 50-99% carotid stenosis.
Here, we further analyzed the patients according to if they were clinically stable, unstable or highly unstable –
respectively defined as having 0, 1 or ≥2 additional ipsilateral events within 7 days before and/or after the ischemic
cerebrovascular event for which the patient sought health care (the presenting event).
Results: Of the 230 included patients, 155 (67%) were clinically stable, 47 (20%) were clinically unstable and 28
(12%) were clinically highly unstable. Eighteen patients suffered a stroke within 7 days; of these patients, 12 (67%)
were clinically stable. The risk of recurrent ipsilateral ischemic stroke within 7 days was equally high for clinically
stable (8%), unstable (9%) and highly unstable (7%) patients. Fourteen patients had 3–11 additional ipsilateral
events; of these patients, only one suffered a recurrent ipsilateral ischemic stroke.
Conclusions: The seemingly clinical stable symptomatic 50-99% carotid stenosis patients without additional
ipsilateral events have a high risk of recurrent stroke. Patients without additional events should undergo preoperative
evaluation and carotid endarterectomy in the same expedient manner as patients with additional events.
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Patients with additional TIAs before a presenting event
have a higher risk of recurrent stroke afterwards than pa-
tients who seek health care after a single event [1]. For
patients experiencing a TIA, the presence of additional
events within 7 days before a presenting event adds to
the risk stratification after adjustment for the ABCD2
score [1]. The ABCD2 score was amended to ABCD3 by
including one or more additional TIAs within 7 days as a
risk factor [1]. These findings are based on patients with
TIAs of mixed etiologies [1].* Correspondence: elias.johansson@neuro.umu.se
1Department of Pharmacology and Clinical Neuroscience and Department of
Public Health and Clinical Medicine, Umeå University, 901 82 Umeå, Sweden
Full list of author information is available at the end of the article
© 2014 Johansson and Wester; licensee BioMe
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.Symptomatic 50-99% carotid stenosis incurs a high
risk of recurrent stroke [1,2]. Patients with additional is-
chemic events and symptomatic carotid stenosis have a
high risk of perioperative stroke [3-5]. This increased
risk may be the lesser of two evils if these patients also
have a high risk of recurrent stroke before carotid end-
arterectomy (CEA). However, previous studies of pa-
tients with symptomatic carotid stenosis did not analyze
if additional symptoms are risk factors for recurrent
stroke before CEA [2,6-8].
The aim of this study was to examine if repeated ische-
mic events increase the risk of recurrent ipsilateral stroke
at 7 and 90 days among patients with symptomatic 50-d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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endarterectomy.
Methods
This is a secondary subgroup analysis of the Additional
Neurological SYmptoms before Surgery of the Carotid
Arteries – a Prospective study (ANSYSCAP) [9]. In short,
the ANSYSCAP was a single center study that prospect-
ively included 230 consecutive patients with symptomatic
50-99% carotid stenoses. The patients were included at
the Umeå Stroke Center in northern Sweden, between
2007-08-01 and 2009-12-31. Many patients (81%) were
referred from 11 hospitals. We included patients who
were preliminary eligible for CEA, defined as that the pa-
tient underwent a specific preoperative evaluation aimed
at CEA (n = 226) or would have done so before a major
recurrent stroke made CEA not meaningful (n = 4). The
selection for this preoperative evaluation was made by
two stroke specialists; one in neurology and one in in-
ternal medicine together with the vascular surgeon. Co-
morbidities and the degree of stroke sequele (in cases
with stroke) were taken into account. No specific stroke
severity score was used, but as a rule the patient should
be relatively cognitive intact (MMSE ≥25) and be able to
walk unassisted. The observation period for recurrent ip-
silateral ischemic stroke was the first 90 days after the
presenting event. If CEA was performed within 90 days,
patients were observed up to the surgery. During the ob-
servation period, all patients were treated with either
anti-platelet or anti-coagulant medication, 93% were
treated with blood pressure reducing medication and
90% with lipid-lowering medication. In the primary ana-
lysis, we found that TIA or stroke as the presenting event
incurred a higher risk of recurrent ipsilateral ischemic
stroke than amaurosis fugax, but we detected no differ-
ences based on age, sex, or the degree of carotid stenosis
on the symptomatic side [9].
In the present analysis, we used the same endpoint as
the original study – recurrent ipsilateral ischemic stroke
that occurs before CEA and within 90 days after the pre-
senting event. Ipsilateral retinal artery occlusion was also
included with this endpoint (henceforth included as “ip-
silateral ischemic stroke” at all times except when clearly
specified). The endpoints were based on clinical assess-
ment, radiological confirmation was not required. How-
ever, brain computer tomography or magnetic resonance
tomography was performed to rule out a hemorrhagic or
other differential diagnoses. We only analyzed events
that occurred before CEA, excluding all perioperative
events. The presenting event was defined as the last is-
chemic cerebrovascular event (stroke, retinal artery oc-
clusion, TIA, or amaurosis fugax) before the patient
sought health care. We defined ipsilateral as the same
side as the presenting event. Cerebrovascular eventswere ascertained by a combination of patient interview,
medical records from various sources and follow-up by
letter and telephone. In the original study, we recorded
every previous and future cerebrovascular events over a
one year follow-up. To the best of our ability, we re-
corded the duration and vascular territory (right carotid,
left carotid, or posterior circulation) of each event. There
were no hemorrhagic events.
We analyzed the patients based on the number of ipsi-
lateral events within 7 days before or after the presenting
event. For the analysis of events before the presenting
event, we used all ipsilateral events regardless of type
(stroke, retinal artery occlusion, TIA, and amaurosis
fugax). Since the endpoint was ipsilateral ischemic stroke
or ipsilateral retinal artery occlusion after the presenting
event, these events were not used when grouping the pa-
tients. Therefore, for the analysis of events after the pre-
senting event, we only used ipsilateral TIA and ipsilateral
amaurosis fugax (henceforth referred to as ipsilateral
events after the presenting event). We only used events
that occurred before CEA and before the endpoint, if it
was reached.
We grouped the patients based on if they were clin-
ically stable, unstable or highly unstable: Stable pa-
tients had no additional events within 7 days before or
after the presenting event. Unstable patients had one
additional event within 7 days before or after the pre-
senting event. Highly unstable patients had ≥2 add-
itional events within 7 days before and/or after the
presenting event.
We compared the prevalence of clinically stable, un-
stable and highly unstable among the clinical subgroups
according to sex, age, degree of symptomatic carotid sten-
osis, type of presenting event, and TOAST-classification.
We analyzed if the delay between the presenting event
and CEA was affected by if the patients were clinically
stable, unstable or highly unstable. We compared the
risk of recurrent ipsilateral ischemic stroke between
the clinically stable, unstable and highly unstable
patients. We further analyzed if the risk of recurrent
ipsilateral ischemic stroke based additional events be-
fore the presenting event and after the presenting
event separately. Finally, we performed several explora-
tive analyses as specified in the results.
Ethics
The study was audited by the Umeå research ethics
committee, which found that the study did not require
committee approval because it was strictly observational.
Therefore, informed consent was not obtained, in ac-
cordance with the current ethical practice. The study
was registered at www.clinicaltrials.gov (NCT 00514592)
before it was launched. The delay to CEA was not in any
way prolonged for the purpose of the study.
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We calculated the 90-day risk of recurrent ipsilateral is-
chemic stroke with Kaplan-Meier curves. We used CEA
as a censor; therefore, patients that underwent CEA only
contributed to the risk-time before their surgery and all
perioperative events were excluded. The risks at 7 days
were acquired from this survival analysis. We used the
log rank test for differences between subgroups. We also
adjusted all findings for age, sex, degree of symptomatic
carotid stenosis, and type of presenting event using Cox
Regression. The number of days between the presenting
event and CEA was non-parametric; therefore, this delay
was presented as the median and intra quartile range
(IQR). We used the chi-squared-test and Kruskal-Wallis
test where appropriate. We used IBM SPSS 20.0 statis-
tical software for all calculations.
Results
Of the 230 included patients, 155 (67%) were clinically
stable, 47 (20%) were clinically unstable and 28 (12%)
were clinically highly unstable. Patients with stroke or
retinal artery occlusion as presenting event were more
often clinically stable than patients with TIA or amaur-
osis fugax as presenting event (p = 0.004, chi-squared
test), see Figure 1. Patients in the intermediate age group
(65–74 years) tended to be less often clinically stable
than younger (<65 years) or older (≥75 years) patients
(p = 0.060, chi-squared test). The delay between the pre-
senting event and CEA, and hence the observation time,































Figure 1 Prevalence of additional ipsilateral events. Numbers inside ba
artery occlusion; Afx = amaurosis fugax; LAA = large artery atherosclerosisAdditional events and risk of recurrent ipsilateral
ischemic stroke
Thirty-two patients suffered a none-fatal and one patient
suffered a fatal recurrent ipsilateral ischemic stroke
within 90 days of the presenting event. Eighteen patients
suffered a recurrent ipsilateral ischemic stroke within
7 days after the presenting event. Twelve (67%) of these
patients were clinically stable, 4 (22%) were clinically un-
stable, and 2 (11%) were clinically highly unstable, see
Table 2. The risk of ipsilateral ischemic stroke was not
statistically significantly affected by if the patient was
clinically stable, unstable or highly unstable (Table 2,
Figure 2). We analyzed the risk of recurrent ipsilateral
ischemic stroke based additional events before the pre-
senting event and after the presenting event separately:
we found non-significant trends that 1 additional ipsilat-
eral event within 7 days before the presenting event in-
curred a higher risk of recurrent ipsilateral ischemic
stroke than 0 or ≥2 events (Figure 3, Table 2); whereas
the opposite pattern was observed in patients with 1
additional event after the presenting event (Figure 4,
Table 2). After adjustment for age, sex, degree of symp-
tomatic carotid stenosis and type of presenting event
using Cox Regression, all tendencies were weaker or
similar, see Table 3.
We also conducted explorative analyses: We explored
the association between type of presenting event and
clinical stability regarding the 18 recurrent ipsilateral is-
chemic strokes that occurred within 7 days of the pre-
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Table 1 Delay between the presenting event and CEA







Number of patients 155 47 28




4.0 (2.7-6.4)* 2.1 (1.1-3.7)*
CEA within 7 days
n (%)
1 (1) 3 (6) 6 (21)
CEA within 14 days
n (%)
18 (12) 6 (13) 12 (43)
CEA within 30 days
n (%)
56 (36) 22 (47) 20 (71)
CEA within 90 days
n (%)
102 (66) 35 (75) 25 (89)
CEA Carotid EndArterectomy. IQR Inter Quartile Range.
* p < 0.001 (Kruskal-Wallis test).
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ical stability and type of presenting event (p = 0.76; Cox
Regression). We further repeated the Kaplan Meier ana-
lysis of the risk of recurrent ipsilateral ischemic stroke
based on additional events within 7 days before the pre-
senting event, but limited to the 70 patients with TIA
(excluding amaurosis fugax) as the presenting event.
The findings were similar to those for the entire study
with a tendency that 1 additional event before the pre-
senting event incurred a higher risk of recurrent ipsilat-
eral ischemic stroke than 0 or ≥2 events (p = 0.08; log
rank test). We also repeated the Kaplan Meier analyses
for all patients, but grouped the patients based on if
additional ipsilateral events occurred within 90 days
(not 7 days) before and/or after the presenting event.Table 2 Number and risk of ipsilateral ischemic strokes on da
number of additional events
Patients
Stroke
n (%) n (%*
Clinically stable 155 (67) 12 (67
Clinically unstable 47 (20) 4 (22
Clinically highly unstable 28 (12) 2 (11
0 events 7 days before the presenting event 183 (80) 14 (78
1 event 7 days before the presenting event 32 (14) 3 (17
≥2 events 7 days before the presenting event 15 (7) 1 (6)
0 events 7 days after‡ the presenting event 188 (82) 15 (83
1 event 7 days after‡ the presenting event 27 (12) 1 (6)
≥2 events 7 days after‡ the presenting event 15 (7) 2 (11
* Percent of all strokes. † Log rank test. ‡ Events after the presenting event: Only ad
ipsilateral ischemic stroke were analyzed.
Risk figures derived from Kaplan-Meier analyses.All associations were similar or weaker compared to the
original analyses.
Patients with several additional events
Fourteen patients (6%) had ≥3 additional ipsilateral
events within 7 days before and/or after the presenting
event. Of these patients, 7 (50%) had 3–6 additional ip-
silateral events and 7 (50%) had 7–11 additional ipsilat-
eral events. Including the presenting event, 5 (36%) had
only amaurosis fugax events, 4 (29%) had only TIA
events, and 5 (36%) had a mix of stroke, TIA, and
amaurosis fugax events. One (7%) of these patients suf-
fered a recurrent ipsilateral ischemic stroke two days
after the presenting event. Eight patients (3%) had ≥10
(range 12–30) additional ipsilateral events within
90 days before and/or after the presenting event. In-
cluding the presenting event, 3 (38%) had only amaur-
osis fugax events, 2 (25%) had only TIA events, and 3
(38%) had a mix of stroke, TIA, and amaurosis fugax
events. None of these eight patients suffered a recur-
rent ipsilateral ischemic stroke after the presenting
event.
Patients with only cerebral events or retinal events
We analyzed how often patients suffer only cerebral
events (stroke and TIA) or only retinal events (ret-
inal artery occlusion and amaurosis fugax). First, we
considered the 110 patients with additional ipsilat-
eral events (including endpoint events) within 90 days
before and/or after the presenting event. In 62/70
(89%) patients with a cerebral presenting event, all
the additional events were cerebral. In 31/40 (78%)
patients with a retinal presenting event, all theys 7 and 90 after the presenting event, according to the
7 days 90 days p-value
s Risk Strokes Risk
) % (95%CI) n (%*) % (95%CI)
) 8% (4–12) 22 (67) 18% (10–25)
p = 0.47†) 9% (1–17) 9 (27) 24% (10–39)
) 7% (0–17) 2 (6) 7% (0–17)
) 8% (4–12) 24 (73) 17% (10–24)
p = 0.14†) 10% (0–20) 8 (24) 35% (13–57)
7% (0–19) 1 (3) 7% (0–19)
) 8% (4–12) 30 (91) 20% (13–28)
p = 0.33†4% (0–11) 1 (3) 4% (0–11)
) 13% (0–31) 2 (6) 13% (0–31)
ditional TIA or amaurosis fugax that occurred before CEA and before recurrent
Figure 2 Kaplan Meier analysis of the risk of recurrent ipsilateral stroke after the presenting event with patients divided by number of
events within 7 days before and/or after the presenting event: Clinically stable (0 events), clinically unstable (1 event), and clinically
highly unstable (≥2 events). CEA was used a censor.
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the 33 patients that reached the endpoint. In 29/30 (97%)
patients with ipsilateral ischemic stroke as the endpoint
event, all preceding events were cerebral. In 1/3 (33%)
patients with recurrent ipsilateral retinal artery occlusion
as the endpoint event, all preceding events were retinal;Figure 3 Kaplan Meier analysis of the risk of recurrent ipsilateral stro
additional events within 7 days before the presenting event. CEA waswhile, one patient had a single TIA and one had several
TIAs as preceding events.
Discussion
The main findings of this study were that the risk of re-
current ipsilateral ischemic stroke was similar regardlesske after the presenting event with patients divided by number of
used a censor.
Figure 4 Kaplan Meier analysis of the risk of recurrent ipsilateral stroke after the presenting event with patients divided by number of
additional events within 7 days after the presenting event. CEA was used a censor.
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or after the presenting event and that the majority of re-
current strokes occurred in patients without additional
events (i.e. in clinically stable patients).
At least in our clinical practice, a patient with add-
itional events is perceived as being at high risk for a re-
current stroke. Therefore, additional events initiate an
extraordinary effort with expedient preoperative evalu-
ation and early CEA - hence, the shorter delay to CEA
for patients with additional events in this study. During
the time period of this study, this meant the patient was
transferred the next office day and stayed until the oper-
ation. Those measures are currently standard practice;
whereas, extraordinary measures are now transfers and




Clinically highly unstable 0.6
0 events 7 days before the presenting event 1.0
1 event 7 days before the presenting event 2.1
≥2 events 7 days before the presenting event 0.6
0 events 7 days after* the presenting event 1.0
1 event 7 days after* the presenting event 0.3
≥2 events 7 days after* the presenting event 1.0
* For events after the presenting event: Only additional TIA or amaurosis fugax that
were analyzed.
† Adjusted for age, sex, degree of symptomatic carotid stenosis and type of presenOne additional event within 7 days before the present-
ing event had a tendency to incur an increased risk of
recurrent stroke, especially among patients with TIA as
the presenting event. There are several study limitations
to consider when interpreting this finding: (1) Although
the patients were prospectively included, the data for
events the days before the presenting event were ascer-
tained retrospectively. (2) Patients with additional events
underwent CEA early because this reduced the observa-
tion time in this group. (3) The most important limita-
tion is the moderate statistical power (230 patients and
33 outcome events), especially when interpreting nega-
tive subgroup findings. Given these limitations, it could
be a false negative finding that we could not detect any
difference in risk between those with and withoutteral ischemic stroke
p-value Adjusted hazard ratio† p-value
- 1.0 -
p = 0.34 1.3 p = 0.52
p = 0.55 0.7 p = 0.58
- 1.0 -
p = 0.07 1.9 p = 0.16
p = 0.64 0.9 p = 0.93
- 1.0 -
p = 0.17 0.2 p = 0.15
p = 0.97 0.8 p = 0.78

















Share of recurrent ipislateral ischemic strokes
Stroke Retinal Artery Occlusion TIA Amaurosis fugax
Figure 5 Type of presenting event among the patients with recurrent ipsilateral ischemic stroke within 7 days divided between
clinically stable, unstable and highly unstable. Numbers inside bars denotes number of patients.
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relationship (patients with ≥2 additional events seemed
to have a lower risk) and no consistency (one additional
event after the presenting event tended to be a protect-
ive factor rather than a risk factor), which indicate it was
not a false negative finding. The lack of dose–response
relationship was supported by the finding that patients
with several additional events (≥3 within 7 days or ≥10
within 90 days) seemed to continue to have additional
transient events, but did not have an increased risk of
stroke.
In previous studies of patients with TIAs of mixed eti-
ologies, one or more recurrent event within 7 days before
the presenting event was associated with symptomatic 50-
99% carotid stenosis and lead to an increased risk of
stroke [1]. It is possible that, among patients with TIAs of
mixed etiologies, additional events act as risk factors by
indicating a high risk etiology (i.e. symptomatic 50-99%
carotid stenosis). However, among the patients with this
high risk etiology, additional events at presentation are
not a risk factor for stroke. This contention has already
been reported for large-artery atherosclerosis in a study
with 388 patients with TIAs of mixed etiologies [10]. They
found large-artery atherosclerosis was the etiology with
the highest risk and additional events at presentation were
more common (p < 0.001) among patients with large-
artery atherosclerosis (42%) than patients with cardioem-
bolism (17%), small vessel disease (13%), other causes
(6%), and undetermined causes (24%). Among patients
with large-artery atherosclerosis, 16% of patients with add-
itional events at presentation suffered a stroke during the
90 days follow-up, compared to 23% of patients without
additional events at presentation (p = 0.49). Although an
increased risk for patients with additional events cannot
be ruled out based on our results, it is clear that patients
without additional events have a high risk of stroke recur-
rence and most of the recurrent stroke occurred in this
group. Thus, it was common that patients sought health
care for the first event and suffered a stroke within 7 days,
without a transient event in between.There are two separate clinical implications for the
findings in this study. (1) The risk of recurrent ipsilateral
ischemic stroke was not increased for patients with add-
itional events. This might be a false negative finding and
should be confirmed in further studies; although, the
clinical implication is that the risk of ipsilateral ischemic
stroke in the acute phase might not be sufficiently high
to warrant an emergent CEA, which has a very high risk
of perioperative events (11-20%) among patients with un-
stable symptoms [3-5]. Thus, it is possible that initial
conservative treatment and delayed CEA (perhaps
>48 hours since the last event) are more beneficial for
these patients. (2) The risk of recurrent ipsilateral ische-
mic stroke was high among the patients without add-
itional events and most recurrent strokes occurred in this
group. Therefore, these patients should undergo an expe-
dient preoperative evaluation for an early CEA. Thus,
there is a need to extend expedient management, which
might be reserved for patients with additional events, to
patients without additional events – i.e. to all patients.
Conclusions
Patients with a symptomatic 50-99% carotid stenosis
have a high risk of recurrent stroke even if they do not
experience additional events. The majority of the recur-
rent strokes occur among patients without additional
events; thus, these patients should undergo preoperative
evaluation and carotid endarterectomy in the same expe-
dient manner that currently might be limited to patients
with additional events.
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